Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Sentinel Lymph Node Biopsy Using Patent Blue Dye in Early-Stage Ovarian Cancer: A Prospective Observational Study

NCT07508306 is registered in ClinicalTrials.gov with Faculty of Medicine of Tunis as lead sponsor.

NCT NCT07508306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07508306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Sentinel Lymph Node Biopsy Using Patent Blue Dye in Early-Stage Ovarian Cancer: A Prospective Observational Study
Lead sponsor
Faculty of Medicine of Tunis
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2026
Completion date
February 28, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage ovarian tumors, sentinel lymph node biopsy (slnb)